HJLIW
Income statement / Annual
Last year (2020), Hancock Jaffe Laboratories, Inc. Warrants's total revenue was $4,252.25,
a decrease of 86.39% from the previous year.
In 2020, Hancock Jaffe Laboratories, Inc. Warrants's net income was -$9,135.49.
See Hancock Jaffe Laboratories, Inc. Warrants’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$4,252.25
|
$31,243.00
|
$186,552.00
|
$422,111.00
|
$785,912.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
$70,400.00 |
$419,659.00 |
$810,294.00 |
$0.00 |
| Gross Profit |
$4,252.25 |
$31,243.00 |
$116,152.00 |
$2,452.00 |
-$24,382.00 |
$0.00 |
| Gross Profit Ratio |
1 |
1 |
0.62 |
0.01 |
-0.03 |
0 |
| Research and Development
Expenses |
$4,252.25
|
$2.21 M
|
$1.24 M
|
$649,736.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$4,882.88
|
$4.91 M
|
$6.48 M
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$4,882.88
|
$4.91 M
|
$6.48 M
|
$0.00
|
$0.00
|
$0.00
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$5.46 M |
$4.63 M |
$1.29 M |
| Operating Expenses |
$9,135.13 |
$7.12 M |
$7.72 M |
$6.11 M |
$4.63 M |
$1.29 M |
| Cost And Expenses |
$9,135.13 |
$7.12 M |
$7.79 M |
$6.53 M |
$5.45 M |
$1.29 M |
| Interest Income |
$0.00 |
$49,915.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$6.86 M |
$209,506.00 |
$57,890.00 |
$88,524.00 |
| Depreciation &
Amortization |
$383,972.00
|
$396,665.00
|
$133,419.00
|
$139,213.00
|
$151,174.00
|
$125,423.00
|
| EBITDA |
$374,836.00
|
-$7.23 M
|
-$6.05 M
|
-$7.44 M
|
-$3.18 M
|
-$1.39 M
|
| EBITDA Ratio |
88.15 |
-231.37 |
-32.42 |
-17.63 |
-4.04 |
0 |
| Operating Income Ratio
|
-2.15
|
-245.67
|
-42.11
|
-14.46
|
-5.93
|
0
|
| Total Other
Income/Expenses Net |
-$0.36
|
$49,915.00
|
-$5.19 M
|
-$1.69 M
|
-$929,075.00
|
-$88,347.00
|
| Income Before Tax |
-$9,135.49 |
-$7.63 M |
-$13.04 M |
-$7.79 M |
-$5.59 M |
-$1.38 M |
| Income Before Tax Ratio
|
-2.15
|
-244.07
|
-69.91
|
-18.46
|
-7.11
|
0
|
| Income Tax Expense |
-$0.36 |
$49,915.00 |
$1.67 M |
-$1.48 M |
-$871,185.00 |
$177.00 |
| Net Income |
-$9,135.49 |
-$7.63 M |
-$13.04 M |
-$7.79 M |
-$3.39 M |
-$1.60 M |
| Net Income Ratio |
-2.15 |
-244.07 |
-69.91 |
-18.46 |
-4.31 |
0 |
| EPS |
-0.0006 |
-0.48 |
-1.39 |
-0.83 |
-0.36 |
-0.17 |
| EPS Diluted |
-0.0006 |
-0.48 |
-1.39 |
-0.83 |
-0.36 |
-0.17 |
| Weighted Average Shares
Out |
$15.76 M
|
$15.76 M
|
$9.36 M
|
$9.36 M
|
$9.36 M
|
$9.36 M
|
| Weighted Average Shares
Out Diluted |
$15.76 M
|
$15.76 M
|
$9.36 M
|
$9.36 M
|
$9.36 M
|
$9.36 M
|
| Link |
|
|
|
|
|
|
